Loading company…
Won 3 federal SBIR/STTR research awards from HHS and other federal agencies.
MANZANITA PHARMACEUTICALS, INC. has been awarded 3 US Small Business Innovation Research (SBIR/STTR) contracts totalling $4,257,704 between 2013 and 2024. These are non-dilutive federal research grants, not equity financing. The company is based in WOODSIDE, California.
3 rounds · latest SBIR Phase II award (HHS), Sep 2024
Sign in to see 3 rounds.
Sign inNo investors recorded yet for MANZANITA PHARMACEUTICALS, INC..
Add an investorMANZANITA PHARMACEUTICALS, INC. has no recorded acquisitions.
Add an acquisitionStill private — no exit on record.
Record an exitNo diversity signals recorded yet for MANZANITA PHARMACEUTICALS, INC..
Add diversity data